| Literature DB >> 32922577 |
Mir Sohail Fazeli1,2, Mir-Masoud Pourrahmat1,2,3, Golshan Massah1,3, Kelsey Lee1,4, Pascal M Lavoie1,4, Mirfarhang Fazeli1,3, Alison Esser5, Jean-Paul Collet1,6.
Abstract
BACKGROUND: Shift work is a necessary part of many industries; however, it can have detrimental effects on health over time.Entities:
Keywords: autonomic nervous system; inflammation; massage; randomized controlled trial; shift work
Year: 2020 PMID: 32922577 PMCID: PMC7454237
Source DB: PubMed Journal: Int J Ther Massage Bodywork
Figure 1Study design.
Figure 2Consolidated Standards of Reporting Trials (CONSORT) flow diagram.
Demographic and Clinical Characteristics of Participantsa
| Female, n (%) | 9 (75) | ||
| Age (range in years) | 28 (26–30) | ||
|
| |||
|
| |||
| HF (ms2) | 127 (80 to 277) | 265 (157 to 453) | .11 |
| TP (ms2) | 675 (287 to 818) | 1029 (319 to 1415) | .13 |
| Pre-ejection period (ms) | 120 (116 to 125) | 122 (116 to 125) | .86 |
| Heart rate (beats/min) | 77 (61 to 81) | 70 (58 to 82) | .05 |
|
| |||
|
| |||
| IL-6 (pg/ml) | 0.3 (0.3 to 0.5) | 0.5 (0.3 to 0.8) | .01 |
| IL-8 (pg/ml) | 3.7 (3.4 to 4.4) | 4.2 (3.3 to 5.5) | .37 |
| TNF-alpha (pg/ml) | 1.6 (1.4 to 1.9) | 1.8 (1.5 to 2.1) | .29 |
|
| |||
|
| |||
| Systolic (mmHg) | 114 (102 to 118) | 114 (105 to 125) | .33 |
| Diastolic (mmHg) | 78 (74 to 82) | 78 (70 to 91) | .26 |
Values are median (interquartile range)
P values are reported using Wilcoxon signed-rank test
HRV = heart rate variability; HF = high frequency; ICG = impedance cardiography; IL = interleukin; TNF-alpha = tumor necrosis factor alpha; TP = total power.
Comparison Between Massage Intervention and Reading Controla
| HF (ms2) | 185 (112 to 315) | 62% (−1 to 150) | 200 (88 to 370) | 14% (−10 to 51) | .16 |
| TP (ms2) | 675 (310 to 1910) | 44% (12 to 138) | 617 (217 to 1346) | 25% (15 to 85) | .40 |
| Pre-ejection period (ms) | 121 (116 to 126) | 1% (0 to 2) | 119 (115 to 128) | 0% (−1 to 1) | .24 |
| Heart rate (beats/min) | 78 (65 to 85) | −4% (−8 to 1) | 72 (67 to 91) | −3% (−5 to 0) | .89 |
|
| |||||
|
| |||||
| IL-6 (pg/ml) | 0.5 (0.4 to 1.1) | −9.0% (−28.4 to 6.8) | 0.4 (0.3 to 0.6) | −4.2% (−12.9 to 5.7) | .37 |
| IL-8 (pg/ml) | 4.0 (3.2 to 6.7) | −5.4% (−26.3 to 8.0) | 3.4 (3.3 to 3.8) | −2.6% (−6.7 to 2.7) | .37 |
| TNF-alpha (pg/ml) | 1.8 (1.5 to 2.4) | −2.5% (−6.7 to 1.7) | 1.8 (1.5 to 2.0) | −1.5% (−6.6 to 3.6) | .18 |
|
| |||||
|
| |||||
| Systolic (mmHg) | 113 (105 to 119) | −1% (−3 to 3) | 109 (104 to 127) | −3% (−6 to −2) | .13 |
| Diastolic (mmHg) | 77 (73 to 89) | 1% (−2 to 4) | 78 (69 to 90) | −3% (−4 to 9) | .86 |
Values are median (interquartile range)
P value is for the comparison between massage and reading relative changes; values are reported using Wilcoxon signed-rank test
HRV = heart rate variability; HF = high frequency; ICG = impedance cardiography; IL = interleukin; TNF-alpha = tumor necrosis factor alpha; TP = total power.
Effect of Massage Intervention and Reading Control on Outcomesa
| HF (ms2) | 185 (112 to 315) | 358 (157 to 476) | .04 | 200 (88 to 370) | 207 (95 to 531) | .78 |
| TP (ms2) | 675 (310 to 1910) | 868 (662 to 2560) | .07 | 617 (217 to 1346) | 807 (294 to 1740) | .04 |
| Pre-ejection period (ms) | 121 (116 to 126) | 123 (116 to 126) | .16 | 119 (115 to 128) | 121 (116 to 129) | .58 |
| Heart rate (beats/min) | 78 (65 to 85) | 73 (62 to 85) | .07 | 72 (67 to 91) | 73 (64 to 89) | .05 |
|
| ||||||
|
| ||||||
| IL-6 (pg/ml) | 0.5 (0.4 to 1.1) | 0.6 (0.2 to 0.9) | .70 | 0.4 (0.3 to 0.6) | 0.4 (0.3 to 0.8) | .59 |
| IL-8 (pg/ml) | 4.0 (3.2 to 6.7) | 3.4 (2.8 to 4.5) | .27 | 3.4 (3.3 to 3.8) | 3.3 (3.0 to 3.8) | .42 |
| TNF-alpha (pg/ml) | 1.8 (1.5 to 2.4) | 1.8 (1.4 to 2.2) | .12 | 1.8 (1.5 to 2.0) | 1.7 (1.4 to 2.0) | .59 |
|
| ||||||
|
| ||||||
| Systolic (mmHg) | 113 (105 to 119) | 114 (102 to 118) | .67 | 109 (104 to 127) | 106 (100 to 120) | .05 |
| Diastolic (mmHg) | 77 (73 to 89) | 79 (74 to 87) | .62 | 78 (69 to 90) | 77 (73 to 89) | .79 |
Values are median (interquartile range)
P values are reported using Wilcoxon signed-rank test
HRV = heart rate variability; HF = high frequency; ICG = impedance cardiography; IL = interleukin; TNF-alpha = tumor necrosis factor alpha; TP = total power.
Hours of Sleep Self-Reported by Individual Participants on Night Shift
| 1 | 0.7 | 2.5 |
| 2 | 0.0 | 0.0 |
| 3 | 3.0 | 0.8 |
| 4 | 1.5 | 0.0 |
| 5 | 0.0 | 0.0 |
| 6 | 1.5 | 0.0 |
| 7 | 0.0 | 0.5 |
| 8 | 4.0 | Not available (lost to follow-up) |
| 9 | 3.0 | 1.0 |
| 10 | 0.0 | 1.5 |
| 11 | 2.0 | 3.5 |
| 12 | 1.5 | 2.5 |